HUMULIN R biosynthetic human neutral insulin 100IU/mL injection multidose cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

humulin r biosynthetic human neutral insulin 100iu/ml injection multidose cartridge

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; metacresol; hydrochloric acid; glycerol - other conditions: refrigerate - do not freeze. indications: for the treatment of insulin dependent diabetic patients.

HUMULIN R insulin 100IU/mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

humulin r insulin 100iu/ml injection vial

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, solution - excipient ingredients: metacresol; glycerol; water for injections; hydrochloric acid; sodium hydroxide - indications as at 05 feb 2002 : humulin is indicated for the treatment of insulin - dependant diabetic patients.

HUMULIN NPH biosynthetic human isophane insulin 100IU/mL injection multidose cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

humulin nph biosynthetic human isophane insulin 100iu/ml injection multidose cartridge

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: water for injections; sodium hydroxide; protamine sulfate; phenol; dibasic sodium phosphate heptahydrate; glycerol; metacresol; hydrochloric acid; zinc oxide - for the treatment of insulin dependent diabetic patients.

HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection multidose cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

humulin 30/70 biosynthetic human 30% neutral 70% isophane insulin 100iu/ml injection multidose cartridge

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide; protamine sulfate; metacresol; zinc oxide; glycerol; dibasic sodium phosphate heptahydrate; phenol - for the treatment of insulin dependent diabetic patients.

HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection 10mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

humulin 30/70 biosynthetic human 30% neutral 70% isophane insulin 100iu/ml injection 10ml vial

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: zinc oxide; water for injections; phenol; sodium hydroxide; glycerol; metacresol; protamine sulfate; hydrochloric acid; dibasic sodium phosphate heptahydrate - for the treatment of insulin dependent diabetic patients.

HUMULIN NPH human insulin 100IU/mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

humulin nph human insulin 100iu/ml injection vial

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: sodium hydroxide; glycerol; metacresol; zinc oxide; phenol; dibasic sodium phosphate heptahydrate; protamine sulfate; hydrochloric acid; water for injections - this product accepted for registration as 'currently supplied' at the time of commencement of the act. humulin is indicated for the treatment of insulin-dependent diabetic patients.

HUMULIN 3070 INJECTION 100 iuml Singapore - English - HSA (Health Sciences Authority)

humulin 3070 injection 100 iuml

eli lilly (singapore) pte ltd - insulin isophane (human); soluble insulin (human) - injection - 70.00% - insulin isophane (human) 70%; soluble insulin (human) 30%

Insulin Human Winthrop European Union - English - EMA (European Medicines Agency)

insulin human winthrop

sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insulin human winthrop rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.

Insulin lispro Sanofi European Union - English - EMA (European Medicines Agency)

insulin lispro sanofi

sanofi winthrop industrie - insulin lispro - diabetes mellitus - drugs used in diabetes - for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. insulin lispro sanofi is also indicated for the initial stabilisation of diabetes mellitus.

HUMALOG MIX50 KwikPen Insulin lispro 100IU/mL injection multidose syringe Australia - English - Department of Health (Therapeutic Goods Administration)

humalog mix50 kwikpen insulin lispro 100iu/ml injection multidose syringe

eli lilly australia pty ltd - insulin lispro, quantity: 100 iu/ml - injection, suspension - excipient ingredients: sodium hydroxide; water for injections; metacresol; protamine sulfate; dibasic sodium phosphate heptahydrate; phenol; glycerol; zinc oxide; hydrochloric acid - indications: for the treatment of patients with type i (iddm) and type ii (niddm) diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.